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Summary
BACKGROUND: Perinatal asphyxial encephalopathy oc-
curs in 1– per 1000 live births and is associated with high
mortality and morbidity. Therapeutic hypothermia in-
creases intact survival and improves neurodevelopmental
outcome in survivors.
AIMS: To evaluate (i) the opinion and practice of thera-
peutic hypothermia as a therapy for moderate to severe
perinatal asphyxial encephalopathy amongst Swiss
neonatologists and paediatric intensive care specialists, (ii)
the current clinical management of infants with perinatal
asphyxial encephalopathy and (iii) the need for a national
perinatal asphyxia and therapeutic hypothermia registry.
METHODS: Two web-based questionnaires were sent to
18 senior staff physicians within the Swiss Neonatal Net-
work.
Abbreviations
aEEG Amplitude integrated Electroencephalogram
CI Confidence Interval
CT Computed Tomography
cUS Cranial Ultrasound
EEG Electroencephalogram
FU Follow-up
MRI Magnetic Resonance Imaging
MRS Magnetic Resonance Spectroscopy
RESULTS: Therapeutic hypothermia was considered ef-
fective by all responders, however only 11 of 18 units
provided therapeutic hypothermia. Cooling was initiated
during transfer and performed passively in 82% of centres
with a target rectal temperature of 33–34 °C. Most units
ventilated infants with perinatal asphyxial encephalopathy
if clinically indicated and 73% of responders gave an-
algesia routinely to cooled infants. Neuromonitoring in-
cluded continuous amplitude integrated EEG (aEEG) and
EEG. Neuroimaging included cranial ultrasound (cUS),
magnetic resonance imaging (MRI) and computed tomo-
graphy (CT). Sixty-seven percent of units treating infants
with perinatal asphyxial encephalopathy performed MRI
routinely. All heads of departments questioned indicated
that a “Swiss National Asphyxia and Cooling Registry” is
needed.
CONCLUSIONS: In Switzerland, access to therapeutic hy-
pothermia is widespread and Swiss neonatologists believe
that therapeutic hypothermia for perinatal asphyxia is ef-
fective. National cooling protocols are needed for the man-
agement of infants with perinatal asphyxial encephalopathy
in order to ensure safe cooling, appropriate monitoring,
imaging and follow-up assessment. A national registry is
needed to collect data on diagnosis, treatment, adverse
events and outcome.
Key words: neonatal encephalopathy; hypothermia;
national registry
Introduction
Perinatal asphyxial encephalopathy is a clinically defined
syndrome of disturbed neurologic function in the earliest
days after birth in infancy, manifested by difficulty with
initiating and maintaining respiration, depression of muscle
tone and reflexes, subnormal level of consciousness and
often seizures [1]. Perinatal asphyxial encephalopathy is a
major cause of death and disability worldwide occurring
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in 1–2 per 1000 births in the developed world [2, 3]; in
low resource settings, the incidence is much higher [4, 5].
Moderate to severe encephalopathy is associated with high
mortality and morbidity rates; sequelae of early brain in-
jury require significant resources.
Experimental studies have shown that neural damage after
hypoxia-ischaemia is delayed for several hours and that
prolonged, moderate hypothermia reduces cerebral injury
and improves neurological outcome [6–8]. Clinical studies
have shown a reduction in mortality and long-term
neurodevelopmental disability at 12 to 24 months of age
with the most benefit seen in moderately encephalopathic
infants [9–14]. Meta-analyses of the trials of therapeutic
hypothermia [11, 15, 16] consistently show that therapeutic
hypothermia increases survival with normal neurological
function (pooled risk ratio of 1.53) with a number needed
to treat of 8 (95% confidence interval (CI) 5–17), and in
survivors it reduces the rates of severe disability and cereb-
ral palsy [17, 18]. The most recent randomised controlled
hypothermia trial (Neo.nEURO.network RCT) reported a
number needed to treat of 4 [95% CI: 3–9]). Furthermore,
therapeutic hypothermia also had a statistically significant
protective effect in the group with severe encephalopathy
(n = 77; p = .005; odds ratio: 0.17 [95% CI: 0.05–0.57])
[19].
Following the completion of the recruitment phase of the
Whole Body Hypothermia for the Treatment of Perinatal
Asphyxial Encephalopathy (TOBY) trial in December
2006, therapeutic hypothermia continued to be offered as
a therapy outside of any clinical trial in some UK units.
A UK national registry was set up to provide surveillance
of the use of therapeutic hypothermia in clinical practice
and to identify possible complications of this therapy out-
side a clinical trial [13]. Even before the publication of
the UK TOBY trial [20], access to hypothermia was wide-
spread in the UK with more than half of the responders of
a UK survey considering therapeutic hypothermia effect-
ive [20]. In the US in 2006, the American Academy of
Paediatrics Committee on Fetus and Newborn stated that
now that clinical trials had stopped recruiting, registries
of infants with perinatal asphyxial encephalopathy should
be established to facilitate data collection regarding dia-
gnoses, treatments and outcomes [12]. Following the pub-
lication of the TOBY trial, the National Institute for Health
and Clinical Excellence (NICE) endorsed Therapeutic Hy-
pothermia with Intracorporeal Temperature Monitoring for
Hypoxic Perinatal Brain Injury in 2010. NICE guidelines
specify that therapeutic hypothermia should be performed
“in carefully selected infants”, “in units experienced in the
care of severely asphyxiated infants” who “enter details
of infants undergoing cooling into the UK TOBY cooling
registry” (see website: http://www.nice.org.uk/nicemedia/
live/11315/48809/48809.pdf).
The aim of this Swiss study was to undertake a survey
among neonatologists and paediatric intensive care special-
ists within Switzerland to (i) evaluate opinion regarding the
use of therapeutic hypothermia, (ii) assess current clinical
management of infants with perinatal asphyxial encephalo-
pathy and (iii) assess opinion of the need for a national re-
gistry.
Methods
The Swiss Neonatal Network & Follow-Up Group is a non-
profit voluntary collaboration of health care professionals
dedicated to improving the quality and safety of medic-
al care for high-risk newborn infants and their families.
The Network consists of all neonatal Intensive Care Un-
its (NICUs), Special Baby Care Units (SBCU) and most
Neuropaediatric Centres in Switzerland under the auspices
of the Swiss Society of Neonatology. A list of heads of de-
partments of neonatal and paediatric intensive care units
was obtained from the Swiss Neonatal Network and in May
2009, a 32 item web-based questionnaire with focus on
clinical management of infants with perinatal asphyxial en-
cephalopathy was sent out to the heads of departments of
18 neonatal units in Switzerland (see appendix 1). An ad-
ditional 25 item questionnaire with detailed questions on
follow-up procedures was sent in March 2010 to the same
neonatal units (see appendix 2). Reminders were sent four
weeks later.
In Switzerland, neonatal units are divided into two main
categories. Those which initially stabilise the infants and
then transfer the infants to regional centres for further care,
and those which provide neonatal intensive care beyond the
initial stabilisation period.
Results
The response rates of the first and second questionnaires
were 67% (12/18) and 94% (17/18), respectively. Of the re-
sponding neonatal units, 11/17 provided mechanical vent-
ilation beyond the stabilisation period. Of the non-respon-
ders, all were units not providing mechanical ventilation
beyond the stabilisation period. The hospitals’ delivery rate
was 1000–3000/year in 15/17 (88%) of the responding
units, 3000–5000/year in 1/17 (6%) units and one unit
has no inborn infants. Almost half of the responding units
(8/17) had a birth rate of 5000–10000/year within their
catchment area, 4/17 (24%) had a birth rate of 3000–5000/
year within their catchment area and 3/17 (18%) units of
1000–3000/year, and two units did not answer this ques-
tion.
A total of 88% (15/17) of the responding units treat infants
with perinatal asphyxial encephalopathy. The remaining
two units transfer any infant with perinatal asphyxial en-
Figure 1
Timing of MRI in the units (n = 10) that routinely perform MRI in all
infants with perinatal encephalopathy. MRS: Magnetic Resonance
Spectroscopy.
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cephalopathy to their regional centre for further care. Of
those units treating such infants, 73% (11/15) provided
therapeutic hypothermia on their unit and 27% (4/15) of the
units refered severely sick infants to their regional centre
for further care and/or cooling. Units that do not offer
therapeutic hypothermia are those which do not provide
mechanical ventilation beyond the initial stabilisation.
In the first questionnaire, the majority of responders felt
that therapeutic hypothermia is effective; only one centre
felt more evidence is necessary to offer therapeutic hypo-
thermia. The second questionnaire showed that during the
interim period, 5/17 (30%) of heads of department were in-
fluenced by the UK TOBY trial results, published in 2009,
and all of the responder considered therapeutic hypother-
mia as an effective therapy. None of the neonatal units have
taken part in trials for therapeutic hypothermia. All respon-
ders felt it important and necessary to build up a national
registry of infants with perinatal asphyxial encephalopathy
to facilitate data collection with focus on clinical manage-
ment, adverse events and follow-up data.
Cooling on transfer
If transport is needed, 77% (13/17) initiated cooling during
transport and cooling was always done passively during
transport.
Hypothermia
Eleven of the 17 (65%) responding units provided thera-
peutic hypothermia. All units providing therapeutic hypo-
thermia performed whole body cooling. A total of 82% (8/
11) of units that offer therapeutic hypothermia aimed to
cool passively. If the target temperature cannot be achieved
or maintained by passive cooling, then a cooling mattress
device was used in 54% (6/11) of the units to reach target
temperature. The duration of cooling was 72 hours in all
centres. Cooling details and clinical management during
the cooling period are found in table 1.
Neuromonitoring
Neurological examinations to assess the severity of the
perinatal asphyxial encephalopathy was done in 94% (16/
17) of all responding units using the Sarnat Score [21] and
in one unit (6%) using both Thompson [22] and Sarnat
Score.
All units providing therapeutic hypothermia therapy (11/
17) used amplitude integrated EEG (aEEG) to monitor
brain function. Seven units (64%) monitored brain function
with aEEG during the cooling and re-warming period, one
unit (9%) was intermittently monitoring with aEEG, two
units (18%) monitored during cooling period only and one
(9%) monitored depending on aEEG availability. Eight
seven percent of the units were using BrainZ monitor and
13% the Olympic 6000 monitor to record aEEG. All re-
sponding units had access to neonatal EEG, however 31%
of the units only operated during office hours. A total of
75% of the units which treat infants with perinatal asphyxi-
al encephalopathy requested EEG between day 1–3 and
25% of the units between day 3 and 7.
Fifty-eight percent of the units treating infants with perinat-
al asphyxial encephalopathy obtained neuroimaging within
the first six hours after birth: all units would use cranial ul-
trasound (cUS). If additional imaging was used within the
first six hours after birth, then MRI was done in 29% of the
units and CT in 14% of the units.
A total of 67% (10/15) of the units treating such infants
performed brain MRI routinely in all infants at any time
Table 1: Clinical management during therapeutic hypothermia in eleven cooling centers.
n (%)
Cooling devices
• Passive cooling
• Cooling mattress
8 (82)
6 (54)
Target temperature
• 32–33 °C
• 33–34 °C
2 (18)
9 (82)
Temperature monitoring
• Rectal temperature
• Oesophageal temperature
• Surface temperature
6 (58)
3 (25)
2 (17)
Mechanical ventilation
• Routinely
• As clinically indicated
3 (25)
8 (75)
Analgesia
• Routinely
• If required
• 1st line medication morphine
8 (73)
3 (27)
11 (100)
Sedation
• Routinely
• If required
• No
• 1st line medication Midazolam
• 1st line medication Chloralhydrate
• Unknown
1 (9)
8 (73)
2 (18)
8 (73)
1 (9)
2 (18)
Seizures
• 1st line medication Phenobarbital
• 1st line medication Midazolam
10 (92)
1 (8)
Relaxation
• Routinely
• If required
None
11 (100)
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during hospitalisation. Timing of MRI is shown in figure 1.
Ninety two percent of all responders used phenobarbital as
first line treatment for seizures and phenytoin as 2nd line
therapy in all units.
Neurodevelopmental assessment
Thirteen of the 17 responding units answered the question
about neurodevelopmental follow-up (FU) assessment.
These centres had different FU programmes for infants
with perinatal asphyxial encephalopathy. The details of FU
assessment are shown in table 2.
Discussion
The birth rate in Switzerland is 10 per 1000 population; the
estimated number of infants with perinatal asphyxial en-
cephalopathy in Switzerland is thus ~76 infants per year. A
recent meta-analysis of the three large hypothermia trials,
showed that moderate hypothermia increased survival with
normal neurological function with a number needed to treat
of eight (95% CI 5 to 17) and in survivors it reduced the
rates of severe disability, cerebral palsy and the mental and
psychomotor developmental index to less than 70 [18].
All neonatologists taking part in this survey believed that
therapeutic hypothermia is effective and offer hypothermia
to infants with perinatal asphyxial encephalopathy even
when transport to a regional centre is necessary. However,
it became evident in these surveys that infants with peri-
natal asphyxial encephalopathy in Switzerland are man-
aged differently depending on where they are treated. This
information emphasises the need for the establishment of
national guidelines for the clinical management of infants
with perinatal asphyxial encephalopathy and of a hypo-
thermia protocol to ensure best clinical practice, treatment
and FU for such infants. Furthermore, a national registry is
mandatory to identify adverse events, to enable systematic
follow-up of survivors and to facilitate further clinical tri-
als of neuroprotection following asphyxia.
Two methods of cooling have been evaluated: whole body
cooling and selective head cooling with mild systemic hy-
pothermia. Whole body cooling relies on the core and deep
brain temperature being similar, while selective head cool-
ing leads to temperature gradients within the brain. Tech-
niques to provide whole body cooling are water mattress
devices (servo controlled or manual and semi-automated),
servo-controlled fans [23], water bottles [24], refrigerated
gel packs with passive cooling at ambient temperature with
cessation of active warming and the radiant warmer turned
off [25], and phase-changing material mattresses [26].
Selective head cooling techniques include the Cool-Cap
system [19] and ice-water-filled rubber gloves or ice packs
applied to the head.
Unlike the large randomised controlled trials of cooling,
in Switzerland 82% (8/11) of the cooling centres aimed to
cool passively. Passive cooling is done by removing ex-
ternal heating devices such as incubators and radiant heat
sources allowing the baby to naturally cool down. Fifty-
four percent of the cooling centres used additional cool-
ing devices to induce and maintain hypothermia during 72
hours if passive cooling does not succeed. To shorten the
time between birth and the start of cooling, most transport
teams of the responding centres initiated cooling already
during transfer.
Cerebral function monitoring using the aEEG has provided
an efficient tool for identifying infants with moderate or
severe encephalopathy or seizures [27, 28] and helps to
predict outcome [28]. A total of 66% of the responding
centres treating infants with perinatal asphyxial encephalo-
pathy and all centres providing therapeutic hypothermia
used aEEG to monitor cerebral function, although not con-
sistently during the cooling period and re-warming phase.
It is important to continuously monitor brain function dur-
ing the cooling and re-warming period as seizures may not
be clinically apparent. However, if such monitoring is used
to select which infants should be treated with therapeutic
hypothermia, knowledge of artefacts which alter the aEEG
trace is important [29].
Fifty-eight percent of the units treating infants with peri-
natal asphyxial encephalopathy acquired early imaging, al-
ways using cranial ultrasound; if additional early imaging
was done then it was mainly done by MRI (29%) or by CT
(14%). cUS is important to document any established in-
jury and to exclude brain malformation on admission [30,
31]. Furthermore, it helps to show the evolution of injury
over time and in combination with Doppler sonography
helps to predict outcome [30, 32, 33]. Severely abnormal
cUS findings were highly predictive of an adverse outcome
at two years of age in infants with perinatal asphyxial en-
cephalopathy; however, normal to mildly abnormal find-
ings were not a strong predictor for favourable outcomes
[30]. MRI is the best imaging modality to detect perinat-
ally acquired cerebral lesions, and the pattern and sever-
ity of lesion are predictive of outcome [34–37]. The timing
of scanning is important as the evolution of injury seen on
MRI progresses over several days and the severity of in-
jury might be underestimated during the first few days after
birth [38]. Rutherford et al published the imaging findings
of the infants of the UK TOBY trial showing that MRI
at a median of 8 days accurately predicted outcome at 18
months in cooled and non-cooled infants [39]. Cooling was
associated with a significant reduction in abnormalities in
the basal ganglia, thalami and white matter, and the pro-
gnostic accuracy of MRI following perinatal asphyxial en-
cephalopathy was not altered by therapeutic hypothermia
[39]. A recent meta-analysis reported deep gray matter lact-
Table 2: Neurodevelopmental follow-up assessment at 2 years in thirteen follow-up centres of the Network.
Neurodevelopmental follow-up assessment n (%)
Neurological examination 11 (85)
Neurodevelopmental assessment 13 (100)
Psychological assessment 4 (32)
MRI 2 (16)
EEG 3 (23)
Original article Swiss Med Wkly. 2011;141:w13145
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 4 of 6
ate/NAA acquired with MRS during the neonatal period to
be the most accurate quantitative MR biomarker for predic-
tion of neurodevelopmental outcome in infants with peri-
natal asphyxial encephalopathy [40]. In this survey, 10 re-
sponders (59%) requested brain MRI in all infants with
perinatal asphyxial encephalopathy and about half of those
(42%) performed MR spectroscopy. It is important to ob-
tain brain MRI in all infants treated with therapeutic hypo-
thermia and if possible the MR sequences should be stand-
ardised.
As infants with perinatal asphyxial encephalopathy are a
high risk population for motor and cognitive impairment
[41–45] and since, even in the absence of motor disability,
long term cognitive deficits such as language and memory
deficits can occur, close and long term neurodevelopmental
assessment should be performed [42, 46]. A total of 87%
(13/15) units treating infants with perinatal asphyxial en-
cephalopathy in Switzerland have established follow-up
programmes for such infants.
In a systematic review of 13 published clinical cooling tri-
als, an increased risk of arrhythmia with a number to treat
to harm of 25 (95% CI 16 to 100) and thrombocytopenia
with a number to treat to harm of 10 (95% CI 5 to 33) in
the hypothermia group was reported [17]. However, these
conditions could be corrected with appropriate clinical care
[17]. Azzopardi et al reported how cooling is managed out-
side of clinical trials in the UK. Reported clinical complic-
ations such as coagulopathy and pulmonary haemorrhage
were thought to be due to asphyxia or other conditions than
hypothermia [13]. National registries give the opportun-
ity to record and monitor adverse events and to help en-
sure that therapeutic hypothermia is applied effectively and
safely in clinical practice.
Conclusion
In Switzerland, access to hypothermia is widespread and
Swiss neonatologists believe that therapeutic hypothermia
is effective. National cooling and follow-up protocols are
needed to standardise management of infants with perinatal
asphyxial encephalopathy to provide safe cooling, appro-
priate monitoring, imaging and follow-up assessment. A
national register is needed to collect data on diagnosis,
treatment, adverse events and neurodevelopmental out-
come.
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